E. Ohman J:or Asset Management AB
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 2009396
STOCKHOLM, V7
Position in TEVA
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$666,758
+$73,997 QoQ
Shares Held
19,680
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#370
of 671 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026E. Ohman J:or Asset Management AB holds $7,864,240 across 6 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
36,937 | $4,097,790 | |
| 2 | ZTS |
Zoetis Inc.
|
15,364 | $1,104,057 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,521 | $824,123 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
19,680 | $666,758 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
3,512 | $591,912 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
40,000 | $579,600 |
All Filings in TEVA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $666,758 | 19,680 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $592,761 | 19,680 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $614,212 | 19,680 | Shares | Sole | 2026-01-12 | |
| No filing history on record for this holder in this stock. | ||||||